BDNF as a Promising Therapeutic Agent in Parkinson’s Disease

Palasz, Ewelina, Wysocka, Adrianna, Gasiorowska, Anna, Chalimoniuk, Malgorzata, Niewiadomski, Wiktor, Niewiadomska, Grazyna·2020·International Journal of Molecular Sciences
DOI 10.3390/ijms21031170

Cites (207)

Items 201–207 of 207

  1. MicroRNA-382 inhibits cell proliferation and invasion of retinoblastoma by targeting BDNF-mediated PI3K/AKT signalling pathway
    Dan Song, Jiandong Diao, Yongjing Yang, Yahong Chen · 2017 · Molecular Medicine Reports
  2. Rolipram improves facilitation of contextual fear extinction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease
    Ken-ichi Kinoshita, Yoshikage Muroi, Toshihiro Unno, Toshiaki Ishii · 2017 · Journal of Pharmacological Sciences
  3. The role of trophic factors and inflammatory processes in physical activity-induced neuroprotection in Parkinson’s disease
    Ewelina Pałasz, Agnieszka Bąk, Anna Gąsiorowska, Grażyna Niewiadomska · 2017 · Postępy Higieny i Medycyny Doświadczalnej
  4. Synthesis, Trafficking and Release of BDNF
    Jianjun Lu, Miao Yang, Ying Sun, Xin‐Fu Zhou · 2014 · Springer eBooks
  5. Promising therapeutic agents for the treatment of Parkinson’s disease
    Majláth, Zsófia, Török, Nóra, Toldi, József, Vécsei, László · 2016 · Expert Opinion on Biological Therapy
  6. Delivery Techniques in Gene Therapy: A Brief Overview
    Daniel Lee John Bunker · 2014 · Journal of Physical Chemistry & Biophysics
  7. Untitled work
    Kordower · 1999 · 10.1002/1531-8249(199909)46:3